Literature DB >> 29788419

Using Vedolizumab to Treat Severe Sweet's Syndrome in a Patient With Ulcerative Colitis.

M Belvis Jiménez1, B Maldonado Pérez1, F Argüelles-Arias1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29788419     DOI： 10.1093/ecco-jcc/jjy066

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  2 in total

1.  Systematic Review: Sweet Syndrome Associated with Inflammatory Bowel Disease.

Authors:  Joseph Sleiman; Asif A Hitawala; Benjamin Cohen; Katie Falloon; Marian Simonson; Benjamin Click; Urmi Khanna; Anthony P Fernandez; Florian Rieder
Journal:  J Crohns Colitis       Date:  2021-11-08       Impact factor: 9.071

2.  Safe and Successful Treatment of Acute Cellular Rejection of an Intestine and Abdominal Wall Transplant With Vedolizumab.

Authors:  Guido Trentadue; Gursah Kats-Ugurlu; Tjasso Blokzijl; Gilles Fh Diercks; Jan Willem Haveman; Klaas Nico Faber; Gerard Dijkstra
Journal:  Transplant Direct       Date:  2020-01-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.